📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $244.68036
- Sector: Healthcare – Drug Manufacturers – General
💡 The Growth Thesis
Buy Consensus: AbbVie Inc. Analysts project a 7.1% potential upside. Currently trading at a Forward P/E of 16.031416.